KLF7 Protein Emerges as Key Driver of Human Cell Reprogramming and Pluripotency

This groundbreaking study reveals that KLF7, a member of the Krüppel-like factor family, serves as a more effective alternative to KLF4 in human cell reprogramming. The research addresses a puzzling discrepancy: while KLF4 is routinely used to generate induced pluripotent stem cells (iPSCs), it's barely detectable in established human pluripotent stem cell lines.

The researchers conducted comprehensive transcriptome analysis of multiple human pluripotent stem cell lines and consistently found minimal KLF4 expression. In contrast, KLF7 showed robust expression levels comparable to other essential pluripotency factors. When they replaced KLF4 with KLF7 in the standard reprogramming cocktail (creating OSK7M instead of OSKM), they successfully generated functional iPSCs from human fibroblasts.

The study demonstrates KLF7's dual role in pluripotency. Beyond enabling initial reprogramming, KLF7 facilitates the transition from conventional to naive pluripotency - a more primitive stem cell state resembling pre-implantation embryos. When researchers overexpressed KLF7 in conventional stem cells, it enhanced chemical resetting to naive pluripotency. Conversely, silencing KLF7 significantly reduced resetting efficiency.

These findings have important implications for regenerative medicine. Naive pluripotent stem cells offer advantages over conventional ones, including better developmental potential and reduced epigenetic barriers. Understanding KLF7's role could lead to more efficient protocols for generating therapeutic stem cells. The research also provides fundamental insights into the molecular networks governing human pluripotency, potentially informing strategies for treating age-related diseases through cellular reprogramming approaches.